Dr. Donohue's research Interests focus on the use of simulation in the NICU and neonatal resuscitation.
Dr. Hoffman's research interests include neuroprotection, telemedicine and simulation.
Dr. Satyan Lakshminrusimha’s research interests are focused on pulmonary transition at birth and disorders of pulmonary transition such as birth asphyxia and persistent pulmonary hypertension of the newborn. His current work on optimal oxygenation in neonatal lung injury evaluates ideal concentrations of inspired oxygen to maintain optimal delivery of oxygen to the brain. He is involved in coming up with novel neonatal resuscitation techniques to enhance return of spontaneous circulation and minimizing brain injury. In addition, he is the principal investigator of a multicenter clinical trial evaluating the role of milrinone in congenital diaphragmatic hernia in the NICHD Neonatal Research Network.
Dr. Kalra's research includes Bronchopulmonary dysplasia and Quality improvement projects.
Dr. Kuhn-Riordon's research interests includes; point of care ultrasound in the NICU, quality improvement and patient safety
Donald Null, M.D. - PubMed
Dr. Null's research focuses on developing less invasive and less damaging modes of ventilation for neonates, including nasal high-frequency ventilation, and testing these novel approaches in the premature lamb.
Dr. Poulain's research investigates the role of selected surfactant apoproteins in the defenses of the lung against environmental pathogens and toxicants.
Dr. Rottkamp's research includes; neurodevelopmental and behavioral outcomes for premature, critically ill infants and other at-risk newborns in the NICU.
Dr. Underwood's research interests are focused on improving nutrition and preventing infections in premature infants. In collaboration with the UC Davis Foods for Health Institute and the UC Davis Functional Glycobiology Program, we are exploring how human milk shapes the composition of the bacteria in the intestine and the developing immune system in premature and term infants. We are conducting clinical trials of probiotics and prebiotics in premature infants and infants with congenital heart disease and gastroschisis. These trials are sponsored by the NIH and the Children’s Miracle Network - more information is available from the NIH's Clinical Trials database. Our goal is to alter the composition of the intestinal bacteria to improve digestion and decrease the risk of a devastating disease of newborns, necrotizing enterocolitis.
Dr. Vali's research Interests include neonatal resuscitation and persistent pulmonary hypertension of the newborn (clinical as well as research in a lamb model).